Abbott Initiates Randomized Clinical Trial in Japan

barbara.lempert Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold – Trial to Study the Innovative “Dissolving” ...

SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing

barbara.lempert SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury MOUNTAIN ...

Seattle Genetics Announces Initiation of Phase 1/2 Trial of Adcetris

barbara.lempert Seattle Genetics Announces Initiation of Phase 1/2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with Bendamustine for Hodgkin Lymphoma Patients after Initial ...

Another Bill To Require Clinical Trial Disclosures, Or Else

esilverman File this under ‘try and try again.’ A US Congressman has, once again, introduced legislation that would require study results to be reported to ClinicalTrials.gov ...

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

barbara.lempert – The H7 VLP vaccine candidate induces an antibody response after a single dose in mice- QUEBEC CITY, June 6, 2013 /CNW/ – Medicago Inc. (TSX: MDG; OTCQX: ...

BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for Treatment of Leukemia

barbara.lempert – Partial results expected in Q4 2013 – JERUSALEM–(BUSINESS WIRE)– BioLineRx (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, ...

FDA official, panelists challenge Avandia safety trial

Carly Helfand Dr. Thomas Marciniak, medical team leader of FDA's Division of Cardiovascular and Renal Products, made some expensive promises Wednesday morning. FiercePharma News

RedHill Biopharma Commences Patient Screening in a Phase IIa Clinical Trial With RHB-104 for Multiple Sclerosis

barbara.lempert RedHill Biopharma Commences Patient Screening in a Phase IIa Clinical Trial With RHB-104 for Multiple Sclerosis   —  The open label Phase IIa study is designed ...

BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU

barbara.lempert SAN RAFAEL, Calif., June 5, 2013 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that it has initiated the Phase 3 program for PEG-PAL ...

Ferrer successfully completes a phase III clinical trial in adult and paediatric patients with impetigo for novel antibacterial compound Ozenoxacin

barbara.lempert Ozenoxacin, a novel bactericidal non-fluorinated quinolone, in development as a topical treatment for impetigo and other infectious dermatological conditions, is now ...

Tesaro and the European Network of Gynecological Oncological Trial Groups Forge Partnership to Develop Niraparib for Ovarian Cancer

barbara.lempert TESARO and the European Network of Gynecological Oncological Trial Groups (ENGOT) Forge Partnership to Develop Niraparib for Ovarian Cancer CHICAGO, June 3, 2013 (GLOBE ...

FDA clamps clinical hold on Pluristem PhII stem cell trial

John Carroll One of the patients enrolled in a mid-stage study for an experimental stem cell therapy from Pluristem Therapeutics suffered a severe allergic reaction, sending him to ...
Page 10 of 12« First...89101112
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS